Authors:
Wong, JMY
Harper, PA
Meyer, UA
Bock, KW
Morike, K
Lagueux, J
Ayotte, P
Tyndale, RF
Sellers, EM
Manchester, DK
Okey, AB
Citation: Jmy. Wong et al., Ethnic variability in the allelic distribution of human aryl hydrocarbon receptor codon 554 and assessment of variant receptor function in vitro, PHARMACOGEN, 11(1), 2001, pp. 85-94
Authors:
Ozdemir, V
Kalow, W
Okey, AB
Lam, MSM
Albers, LJ
Reist, C
Fourie, J
Posner, P
Collins, EJ
Roy, R
Citation: V. Ozdemir et al., Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C -> A polymorphism in intron 1 of the CYP1A2 gene: Effect of grapefruit juice and low-dose fluvoxamine, J CL PSYCH, 21(6), 2001, pp. 603-607
Authors:
Franc, MA
Pohjanvirta, R
Tuomisto, J
Okey, AB
Citation: Ma. Franc et al., Persistent, low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: Effect on aryl hydrocarbon receptor expression in a dioxin-resistance model, TOX APPL PH, 175(1), 2001, pp. 43-53
Citation: Jmy. Wong et al., Human aryl hydrocarbon receptor polymorphisms that result in loss of CYP1A1 induction, BIOC BIOP R, 288(4), 2001, pp. 990-996
Authors:
Pohjanvirta, R
Viluksela, M
Tuomisto, JT
Unkila, M
Karasinska, J
Franc, MA
Holowenko, M
Giannone, JV
Harper, PA
Tuomisto, J
Okey, AB
Citation: R. Pohjanvirta et al., Physicochemical differences in the AH receptors of the most TCDD-susceptible and the most TCDD-resistant rat strains, TOX APPL PH, 155(1), 1999, pp. 82-95